These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 15279636)
21. Expression of Epstein-Barr virus-encoded RNA and biological markers in Italian nasopharingeal carcinomas. Gabusi E; Lattes C; Fiorentino M; D'Errico A; Grigioni WF J Exp Clin Cancer Res; 2001 Sep; 20(3):371-6. PubMed ID: 11718217 [TBL] [Abstract][Full Text] [Related]
22. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254 [TBL] [Abstract][Full Text] [Related]
23. In vivo real-time diagnosis of nasopharyngeal carcinoma in situ by contact rhinoscopy. Wai Pak M; To KF; Lee JC; Liang EY; van Hasselt CA Head Neck; 2005 Nov; 27(11):1008-13. PubMed ID: 16134185 [TBL] [Abstract][Full Text] [Related]
24. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais. Tiwawech D; Srivatanakul P; Karalak A; Ishida T J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201 [TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma. Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177 [TBL] [Abstract][Full Text] [Related]
26. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Zheng H; Li LL; Hu DS; Deng XY; Cao Y Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372 [TBL] [Abstract][Full Text] [Related]
27. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Burgos JS Med Oncol; 2005; 22(2):113-21. PubMed ID: 15965273 [TBL] [Abstract][Full Text] [Related]
28. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma. Lee DC; Chua DT; Wei WI; Sham JS; Lau AS Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445 [TBL] [Abstract][Full Text] [Related]
29. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis. Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113 [TBL] [Abstract][Full Text] [Related]
30. Absence of Epstein-Barr virus infection in squamous cell carcinoma of upper urinary tract and urinary bladder. Ng KF; Chuang CK; Chang PL; Chu SH; Wallace CG; Chen TC Urology; 2006 Oct; 68(4):775-7. PubMed ID: 17070351 [TBL] [Abstract][Full Text] [Related]
31. Absence of Epstein-Barr virus in olfactory neuroblastoma. Wang SL; Li SH; Chen WT; Chai CY Pathology; 2007 Dec; 39(6):565-6. PubMed ID: 18027259 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma. Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452 [TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. de Oliveira DE; Bacchi MM; Macarenco RS; Tagliarini JV; Cordeiro RC; Bacchi CE Am J Clin Pathol; 2006 Aug; 126(2):284-93. PubMed ID: 16891205 [TBL] [Abstract][Full Text] [Related]
34. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma. Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221 [TBL] [Abstract][Full Text] [Related]
35. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma. Chang KP; Hao SP; Lin SY; Ueng SH; Pai PC; Tseng CK; Hsueh C; Hsieh MS; Yu JS; Tsang NM Laryngoscope; 2006 Apr; 116(4):541-6. PubMed ID: 16585856 [TBL] [Abstract][Full Text] [Related]
36. Intrahepatic cholangiocarcinoma with lymphoepithelioma-like carcinoma component. Huang Y; Tsung JS; Lin CW; Cheng TY Ann Clin Lab Sci; 2004; 34(4):476-80. PubMed ID: 15648792 [TBL] [Abstract][Full Text] [Related]
37. Detection of EBV in nasopharyngeal carcinoma by quantum dot fluorescent in situ hybridization. Chen HL; Peng J; Zhu XB; Gao J; Xue JL; Wang MW; Xia HS Exp Mol Pathol; 2010 Dec; 89(3):367-71. PubMed ID: 20858485 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients. Burgos JS; Vera-Sempere FJ Laryngoscope; 2000 Dec; 110(12):2081-4. PubMed ID: 11129025 [TBL] [Abstract][Full Text] [Related]
39. Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases. Li L; Guo L; Tao Y; Zhou S; Wang Z; Luo W; Hu D; Li Z; Xiao L; Tang M; Yi W; Tsao SW; Cao Y Cancer Lett; 2007 Oct; 255(2):219-31. PubMed ID: 17582679 [TBL] [Abstract][Full Text] [Related]
40. Relationship between GAGE-1/-2 expression, EBV infection and interferon-gamma expression in undifferentiated carcinoma of nasopharyngeal type. Schlott T; Middel P; Laskawi R; Brinck U; Ruschenburg I; Droese M Anticancer Res; 2000; 20(3A):1727-32. PubMed ID: 10928100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]